Keystream’s Life Sciences Division expands into the US markets

Share this blog:

By :
Natalie Drew

After two years of continued growth, Keystream’s Life Sciences recruitment division is set to expand into the USA, with the addition of Sasha Flynn to the team.

Covering all segments of the Pharmaceutical industry, including…

  • Contract Development & Manufacturing Organisations (CDMO’s)
  • Contract Research Organisations (CROs)
  • Biotech companies
  • LifeScience companies

…Sasha will be partnering with internal talent acquisition teams on roles across the product development lifecycle.

Her focus will be on hiring critical middle – senior level permanent positions for businesses, including: 

Research & Development: Manufacturing & Production Quality Distribution
Lab-based R&D Process Eningeering Quality Assurance Sales
Clinical Trials Manufacturing Engineering Quality Control Marketing
Regulatory Affairs MSAT Validation  
Pharmacovigilance Bioprocessing Operations  
  Scientists    

Having worked the US market previously, placing scientists in leading CDMOs, she brings a wealth of knowledge and a network of high calibre contacts.

A logical next step

Strategically, this is the next step in the development of the team and, with the addition of Sasha, we are able to accelerate our expansion plans. Here’s why:

1)    Life sciences and pharmaceuticals are strong, vibrant and innovative sectors in the USA, as well as the UK. 

A global sector requires a team with a global mindset, able to tap into those talent pools.  

This is a natural progression for the team as we seek to challenge more established players in the market.

2)    It’s a growing market with huge potential.

The US pharmaceutical industry generated $550 billion in the US in 2021* and accounted for 48% of the global pharmaceutical market in 2020*. 4 million jobs in the US were supported by the pharma industry, directly and indirectly, according to a report by phrma.org 

Experts predict that the global market is set to grow at an annual compound rate of around 7.4%, with investment boosted as a result of the pandemic, even in the current challenging economic conditions*. 

3)     Attracting talent will be key to securing growth  

In a growing, global market with high levels of innovation and investment, talent is a strategic priority. Over the past couple of years, we have seen an explosion of activity and fierce competition for good talent in the market.

Making this an extremely exciting time to be recruiting in the pharma sector!

4)     New technology and the evolution of the workplace 

OK, we don’t have a physical office in the USA. But even if we did, it’s a huge country stretching across several time zones.  

The pandemic was a catalyst for the adoption of flexible working practices. Hybrid and 100% remote working means that talent pools have suddenly increased, no longer restricted by location. 

And, the recruitment process has also changed. Now, video interviews are the norm, indeed it’s not uncommon for the process to be 100% remote. 

At Keystream, we work the hours our market needs, it really doesn’t matter where we’re based. 

The important thing is we have the contacts, know the industry inside out and can apply creative, ‘outside the box’ thinking to challenging talent issues.

If you are a US Pharma company looking for pharmaceutical recruitment support,
or, if you’re exploring new opportunities in the industry, contact Sasha

* Source 
 

Insights

The latest from the Keystream Team

Job seeker help, market insights, EDI support, hiring trends and company news.

It's time to change our Charity of the Year...

Here's a recap of how we helped Hestia in 2022. Read more

Our team has achieved some amazing milestones this year.

Here's a look back at some of our 2022 highlights. More here...

 

Our final 2022 round up of hot topics in Life Sciences & Healthcare, plus, a look ahead to 2023.

Will AI, machine learning & advanced analytics ease pressure. Read on...